• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Technology>Biotechnology

Biotechnology

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

    UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

  2. Canadian Biotech Delivering Solutions to Global Marketplace

    Canadian Biotech Delivering Solutions to Global Marketplace

  3. Feed Enzymes Market to Reach $1.4 Billion by 2022 - Key Players are BASF SE, E. I. du Pont, Associated British Foods, Koninklijke DSM, Adisseo France, Azelis Holdings, Rossari Biotech & Alltech - ...

    Feed Enzymes Market to Reach $1.4 Billion by 2022 - Key Players are BASF SE, E. I. du Pont, Associated British Foods, Koninklijke DSM, Adisseo France, Azelis Holdings, Rossari Biotech & Alltech - Research and Markets

  4. BIO World Congress on Industrial Biotechnology Returns to Montreal

    BIO World Congress on Industrial Biotechnology Returns to Montreal

  5. Reviva Pharmaceuticals Announces Addition of a New Member to its Board of Directors

    Reviva Pharmaceuticals Announces Addition of a New Member to its Board of Directors

  6. Transgene Announces Cancer Research Publication Confirming the Potential of its Next Generation Armed Engineered Oncolytic Virus

    Transgene Announces Cancer Research Publication Confirming the Potential of its Next Generation Armed Engineered Oncolytic Virus

  7. Sartorius Stedim Biotech S.A.: 2017 First-Half Figures

    Sartorius Stedim Biotech S.A.: 2017 First-Half Figures

  8. Sartorius Stedim Biotech : Information on Document Availability

    Sartorius Stedim Biotech : Information on Document Availability

  9. SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017

    SVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017

  10. H.C. Wainwright Analysts Earn Number One Rankings in 2017 Thomson Reuters Analyst Awards

    H.C. Wainwright Analysts Earn Number One Rankings in 2017 Thomson Reuters Analyst Awards

12345

©2017 Morningstar Advisor. All right reserved.